Hot Compress Application in Open Abdominal Surgery
HotCompress
The Effect of Hot Compress Applied on the Intestines on Postoperative Nausea-vomiting and Bowel Function in Abdominal Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
This study aims to evaluate the effect of hot compress application to the intestines during abdominal surgery on postoperative nausea-vomiting and bowel function. Volunteers will be randomly assigned to the intervention and control groups. Initially, 30 patients will be included in each group, and the study will be completed based on the effect size determined by power analysis. Hypotheses: H0: Covering the intestines with saline heated at 36°C during surgery has no effect on postoperative nausea and vomiting. H1: Covering the intestines with saline heated at 36°C during surgery affects postoperative nausea and vomiting. H01: Covering the intestines with saline heated at 36°C during surgery has no effect on postoperative bowel function. H11: Covering the intestines with saline heated at 36°C during surgery affects postoperative bowel function. Inclusion Criteria: Undergoing abdominal surgery in the general surgery ward, Aged 18 years or older, Having a BMI between 18.50-24.99 kg/m², Able to communicate verbally, Willing to participate in the study, Conscious and oriented patients. Exclusion Criteria: History of previous gastrointestinal surgery, Postoperative complications, History of small bowel resection, ileostomy, or colostomy, History of emergency surgery, neoadjuvant therapy, appendectomy, or inflammatory bowel disease, Chronic opioid use, Chronic constipation (≤ 2 bowel movements per week), History of abdominal radiotherapy, Admission to the intensive care unit or postoperative bleeding. Application: Intervention Group: Routine preoperative procedures will be performed. During surgery, the intestines will be covered with sterile gauze soaked in saline heated at 36°C to prevent drying and reduce the risk of infection. Routine postoperative procedures will also be applied. Control Group: Routine preoperative, intraoperative, and postoperative procedures will be applied. During surgery, the intestines will be covered with sterile gauze soaked in unheated saline, following standard practice. Outcome Measures: Primary Outcome: Gastrointestinal function assessment index, including time to first flatulence, first defecation, first normal bowel sounds, and first consumption of liquid/semi-solid food. Secondary Outcome: Gastrointestinal symptoms such as nausea, abdominal bloating, pain, and vomiting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2025
CompletedFirst Posted
Study publicly available on registry
March 21, 2025
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedOctober 6, 2025
October 1, 2025
9 months
March 9, 2025
October 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
will be an index of gastrointestinal functional assessment, including time to first passing gas, first defecation, first normal bowel sounds and first consumption of liquid/semi-general diet foods
Quality of Recovery-15 (QoR-15) Scale Scores: The QoR-15 scale is a validated tool used to assess postoperative recovery quality. It consists of 15 items, each scored on a 0-10 scale, with a total score range of 0 to 150 (higher scores indicate better recovery). Scoring Interpretation: 0 - 70 → Poor recovery 71 - 100 → Moderate recovery 101 - 150 → Good recovery Gastrointestinal Symptom Rating Scale (GSRS) - Scale Scores The Gastrointestinal Symptom Rating Scale (GSRS) is a validated tool used to assess the severity of gastrointestinal (GI) symptoms. It consists of 15 items, each scored on a 7-point Likert scale (1 = no discomfort, 7 = severe discomfort). Scoring Interpretation: Total Score Range: 15 to 105 (higher scores indicate worse GI symptoms). Mean score calculation: Total score is divided by the number of items (15) to determine the severity of symptoms. Interpretation of Scores: 15 - 30 → Mild symptoms 31 - 60 → Moderate symptoms 61 - 105 → Severe symptoms
postoperative 1-3 day
Study Arms (2)
Intervention Group (Hot compress Application)
EXPERIMENTALPatients in this group will be toweled with heated saline during abdominal surgery. After the abdomen is opened, the intestines will be covered with a sterile towel soaked in saline heated to 36°C to prevent drying and reduce the risk of infection.
Control Group (Routine Care)
NO INTERVENTIONPatients in this group will receive standard surgical care.
Interventions
Covering intestines with sterile gauze soaked in 36°C heated saline during surgery to prevent drying and reduce infection risk
Eligibility Criteria
You may qualify if:
- Abdominal surgery in the general surgery ward
- years of age or older
- Patients with BMI in the normal range (18.50-24.99 kg/m2)
- Able to communicate verbally
- Those who volunteered to participate in the study
- Patients with no mental confusion, conscious and oriented will be included.
You may not qualify if:
- Previous gastrointestinal system surgery
- Complications in the postoperative period
- History of small bowel resection and ileostomy or colostomy
- Surgical history of inflammatory bowel diseases, emergency surgery, neoadjuvant therapy, appendectomy,
- Chronic opioid use,
- Experiencing chronic constipation (≤ 2 bowel movements per week),
- Abdominal radiotherapy
- Patients admitted to intensive care unit and patients with bleeding will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TC Erciyes Universitylead
- Kirsehir Ahi Evran Universitesicollaborator
Study Sites (1)
Kırşehir Ahi Evran University
Merkez, Kırşehir, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 9, 2025
First Posted
March 21, 2025
Study Start
May 15, 2025
Primary Completion
February 15, 2026
Study Completion
February 25, 2026
Last Updated
October 6, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share